Distinctive clinicopathological features and KRAS and IDH1/2 mutation status of cholangiolocellular carcinoma

Aim Cholangiolocellular carcinoma (CLC) is classified as a subtype of combined hepatocellular cholangiocarcinoma with stem‐cell features (CHC‐SC) in the latest World Health Organization classification. This subclassification of CHC‐SCs is controversial and the relevance of such classification is unc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology research 2020-01, Vol.50 (1), p.84-91
Hauptverfasser:	Kusano, Hironori, Naito, Yoshiki, Mihara, Yutaro, Kondo, Reiichiro, Ogasawara, Sachiko, Akiba, Jun, Nakashima, Osamu, Yano, Hirohisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma Cholangiocarcinoma cholangiolocellular carcinoma combined hepatocellular cholangiocarcinoma Etiology Fibrosis Hepatitis Histology IDH mutation intermediate cell carcinoma intrahepatic cholangiocarcinoma Liver diseases Medical prognosis Metastases Microvasculature Multivariate analysis Mutation primary liver cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!